Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure

BACKGROUND: The development of heart failure is accompanied by complex changes in cardiac electrophysiology and functional properties of cardiomyocytes and fibroblasts. Histone deacetylase (HDAC) inhibitors hold great promise for the pharmaceutical therapy of several malignant diseases. Here, we des...

Verfasser: Freundt, Johanna K.
Frommeyer, Gerrit
Spieker, Georg Tilmann
Wötzel, Fabian
Schulze Grotthoff, Jochen
Stypmann, Jörg
Hempel, Georg
Schäfers, Michael
Jacobs, Andreas H.
Eckardt, Lars
Lange, Philipp Sebastian
FB/Einrichtung:FB 05: Medizinische Fakultät
Dokumenttypen:Artikel
Medientypen:Text
Erscheinungsdatum:2019
Publikation in MIAMI:28.02.2020
Datum der letzten Änderung:03.01.2023
Angaben zur Ausgabe:[Electronic ed.]
Quelle:BMC Pharmacology and Toxicology 20 (2019) 16, 1-9
Schlagwörter:HDAC; Entinostat; Arrhythmias; Remodeling; Fibrosis
Fachgebiet (DDC):610: Medizin und Gesundheit
Lizenz:CC BY 4.0
Sprache:English
Förderung:Finanziert durch den Open-Access-Publikationsfonds der Westfälischen Wilhelms-Universität Münster (WWU Münster).
This work was supported by the fund “Innovative Medical Research” of the University of Münster Medical School [I-LA11123].
Format:PDF-Dokument
URN:urn:nbn:de:hbz:6-92109546463
Weitere Identifikatoren:DOI: https://doi.org/10.1186/s40360-019-0294-x
Permalink:https://nbn-resolving.de/urn:nbn:de:hbz:6-92109546463
Verwandte Dokumente:
Onlinezugriff:artikel_lange_2019.pdf
LEADER 04551cam a2200493uu 4500
001 1763bf5f-ae20-4469-94ec-833a9f8a3089
003 miami
005 20230103
007 c||||||||||||a|
008 200228e20200228||||||||||#s||||||||eng||||||
024 7 |a urn:nbn:de:hbz:6-92109546463  |2 urn 
024 7 |a https://doi.org/10.1186/s40360-019-0294-x  |2 doi 
041 |a eng 
082 0 |a 610 Medizin und Gesundheit  |2 23 
100 1 |a Freundt, Johanna K.  |0 http://d-nb.info/gnd/1084614642  |0 http://viaf.org/viaf/791145857034922921194  |4 aut 
110 2 |a Universitäts- und Landesbibliothek Münster  |0 http://d-nb.info/gnd/5091030-9  |4 own 
245 1 0 |a Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure 
250 |a [Electronic ed.] 
264 1 |c 2019-03-06 
264 2 |b Universitäts- und Landesbibliothek Münster  |c 2020-02-28 
300 |a 1-9 
506 0 |a free access 
510 0 |a BMC Pharmacology and Toxicology 20 (2019) 16, 1-9 
520 3 |a BACKGROUND: The development of heart failure is accompanied by complex changes in cardiac electrophysiology and functional properties of cardiomyocytes and fibroblasts. Histone deacetylase (HDAC) inhibitors hold great promise for the pharmaceutical therapy of several malignant diseases. Here, we describe novel effects of the class I HDAC inhibitor Entinostat on electrical and structural remodeling in an in vivo model of pacing induced heart failure. METHODS: Rabbits were implanted a pacemaker system, subjected to rapid ventricular pacing and treated with Entinostat or placebo, respectively. Following stimulation, rabbit hearts were explanted and subsequently subjected to electrophysiological studies and further immunohistological analyses of left ventricles. RESULTS: In vivo, rapid ventricular stimulation caused a significant prolongation of monophasic action potential duration compared to sham hearts (from 173 ± 26 ms to 250 ± 41 ms; cycle length 900 ms; p < 0.05) and an increased incidence of Early afterdepolarisations (+ 150%), while treatment with Entinostat in failing hearts could partially prevent this effect (from 250 ± 41 ms to 170 ± 53 ms, p < 0.05; reduction in EAD by 50%). Entinostat treatment partially restored KCNH2 and Cav1.3 gene expressions in failing hearts, and inhibited the development of cardiac fibrosis in vivo. CONCLUSION: In a rabbit model of heart failure, Entinostat diminishes heart failure related prolongation of repolarization and partially restores KCNH2 and Cav1.3 expression. In addition, Entinostat exerts antifibrotic properties both in vitro and in vivo. Thus, Entinostat might be an interesting candidate for the pharmaceutical therapy of heart failure directed against structural and electrical remodeling. 
521 |a specialized 
536 |a Finanziert durch den Open-Access-Publikationsfonds der Westfälischen Wilhelms-Universität Münster (WWU Münster). 
536 |a This work was supported by the fund “Innovative Medical Research” of the University of Münster Medical School [I-LA11123]. 
540 |a CC BY 4.0  |u http://creativecommons.org/licenses/by/4.0/ 
653 0 |a HDAC  |a Entinostat  |a Arrhythmias  |a Remodeling  |a Fibrosis 
655 7 |2 DRIVER Types  |a Artikel 
655 7 |2 DCMI Types  |a Text 
700 1 |a Frommeyer, Gerrit  |0 http://d-nb.info/gnd/1016198868  |4 aut 
700 1 |a Spieker, Georg Tilmann  |0 http://d-nb.info/gnd/173526152  |4 aut 
700 1 |a Wötzel, Fabian  |0 http://d-nb.info/gnd/139263551  |0 http://viaf.org/viaf/100551808  |4 aut 
700 1 |a Schulze Grotthoff, Jochen  |4 aut 
700 1 |a Stypmann, Jörg  |0 http://d-nb.info/gnd/172952247  |0 http://viaf.org/viaf/240986703  |4 aut 
700 1 |a Hempel, Georg  |4 aut 
700 1 |a Schäfers, Michael  |u FB 05: Medizinische Fakultät  |0 http://d-nb.info/gnd/114976449  |0 http://viaf.org/viaf/10565023  |4 aut 
700 1 |a Jacobs, Andreas H.  |0 http://d-nb.info/gnd/1177283832  |4 aut 
700 1 |a Eckardt, Lars  |u FB 05: Medizinische Fakultät  |0 http://d-nb.info/gnd/172952743  |0 http://viaf.org/viaf/213417804  |4 aut 
700 1 |a Lange, Philipp Sebastian  |0 http://d-nb.info/gnd/123970601  |0 http://viaf.org/viaf/15692886  |4 aut 
787 1 8 |i IsIdenticalTo  |o https://doi.org/10.1186/s40360-019-0294-x 
856 4 0 |3 Zum Volltext  |q text/html  |u https://nbn-resolving.de/urn:nbn:de:hbz:6-92109546463  |u urn:nbn:de:hbz:6-92109546463 
856 4 0 |3 Zum Volltext  |q application/pdf  |u https://repositorium.uni-muenster.de/document/miami/1763bf5f-ae20-4469-94ec-833a9f8a3089/artikel_lange_2019.pdf